Tag: Biocon
-
Ajanta Pharma Companions with Biocon to Distribute Semaglutide in 26 International Markets
Ajanta Pharma mentioned it has signed an in-licensing settlement with Biocon to market semaglutide, a GLP-1 receptor agonist, throughout 26 nations spanning Africa, the Center East and Central Asia, as Indian drugmakers sharpen their concentrate on advanced diabetes therapies in rising markets. Underneath the settlement, Biocon will provide semaglutide to Ajanta for unique advertising in…
-
Biocon Biologics and Biocon to Merge: Key Developments within the Biopharmaceutical Sector
Biocon to accumulate stability stake in Biocon Biologics at EV of USD 5.5 billion Biocon introduced a strategic company motion to totally combine Biocon Biologics (BBL) as an entirely owned subsidiary into Biocon, topic to relevant approvals. The Technique Committee, constituted in Might 2025, undertook a complete analysis of a number of strategic choices for…
-
Biocon to Consolidate Biologics Division in $5.5 Billion Merger
Biocon Ltd will combine Biocon Biologics Ltd as an entirely owned subsidiary in a deal valuing the unit at $5.5 billion, the corporate mentioned on Saturday. Biocon will purchase the remaining stake in Biocon Biologics from Serum Institute Life Sciences, Tata Capital Progress Fund II and Activ Pine LLP through a share swap of 70.28…